E-sigaretter på nett
943true dots bottomright 319true true 800http://www.niprd.net/wp-content/plugins/thethe-image-slider/style/skins/white-rounded
  • 5000 random true 60 bottom 30
    Slide1
    NIPRD Head Office
  • 5000 random true 60 bottom 30
    Slide9
    Director General/Chief Executive, Professor K. S. Gamaniel, OON, FAS, FPSN, FPCPharm.
  • 5000 random true 60 bottom 30
    Slide5
    Innovation Award
  • 5000 random true 60 bottom 30
    Slide8
    Our scientists on the bench conducting R&D
  • 5000 random true 60 bottom 30
    Slide8
    Prof. Isaac Adewole, Honourable Minister of Health and Prof. Karniyus Gamaniel, DG NIPRD
  • 5000 random true 60 bottom 30
    Slide11
    Senate Committee on Health pays Oversight Function visit to NIPRD
  • 5000 random true 60 bottom 30
    Slide7
    The DG, NIPRD on PSN delegation on a courtesy visit to President Muhammadu Buhari, GCFR
  • 5000 random true 60 bottom 30
    Slide8
    The President, PSN (Pharm) Ahmed Yakassai visits NIPRD
  • 5000 random true 60 bottom 30
    Slide9
    PSN (Abuja Chapter) new EXCO pays a familiarization/courtesy visit to NIPRD

Introduction

In Nigeria, the need for the advancement of indigenous pharmaceutical research and development (R&D) in order to enhance Development and commercialization of pharmaceutical raw materials, drugs and biological products has long been recognized.

Therefore in 1987, the federal Government approved the establishment of the National Institute for Pharmaceutical Research and Development (NIPRD) as a parastatal under the Federal Ministry of Science and Technology. This approval was based on the recommendation of the pharmaceutical society of Nigeria (PSN).
The Institute was established under the Science and Technology Act of 1980 with the primary objective of developing drugs, biological products and pharmaceutical raw materials from indigenous resources.

 

Our Vision

To build a Centre of Excellence in research and development of phytomedicines, pharmaceutical and biological products, drugs and diagnostics towards improving the health and well-being of mankind.

Our Mission

To apply appropriate modern science and technological resources to stimulate local production of drugs through effective collaboration with the industry and experts within and outside Nigeria;
Develop herbal and phytomedicines to pilot state of commercialization;
Develop quality standards for phytomedicine;
Drugs and diagnostics for the purpose of control and regulation;
Provide quality assurance services on all drugs used in healthcare delivery;
Provide safety data and essential information on herbal and other towards achieving self-sufficiency in the production and control of essential drugs in such a way that would guarantee the overall health of Nigerians and mankind in general.

 

The Pharmaceutical Society of Nigeria (PSN) and the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) made financial contributions toward the take-off of the Institute. A Board of Governors governs the Institute with representations from the PSN, PMG-MAN, Traditional Medicine Practitioners, Federal Ministry of Health (FMH) and Federal Ministry of Science and Technology (FMST) while the Chief Executive serves as member and Secretary to the Board.

The first major activity of the Institute was the organization of an International Workshop on “Strategies and Priorities for Indigenous Pharmaceutical Research and Development” in October 1989. The proceedings of the workshop were published in 1991. In 1990, the Institute embarked on the documentation of medicinal and aromatic plants within the Federal Capital Territory (FCT) of the Federal Republic of Nigeria. The data accumulated during the enthnobotanical survey are being compiled into a National compendium of medicinal and aromatic plants in Nigeria.


picture